| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.1 | 0.03 |